HK1184786A1 - -二氫- -惡唑並 吡嗪- -二酮的衍生物 - Google Patents
-二氫- -惡唑並 吡嗪- -二酮的衍生物Info
- Publication number
- HK1184786A1 HK1184786A1 HK13112233.7A HK13112233A HK1184786A1 HK 1184786 A1 HK1184786 A1 HK 1184786A1 HK 13112233 A HK13112233 A HK 13112233A HK 1184786 A1 HK1184786 A1 HK 1184786A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxazolo
- pyrazine
- dione
- dihydro
- derivatives
- Prior art date
Links
- SPNMSIYOCYTIIH-UHFFFAOYSA-N 6,7-dihydro-3h-[1,3]oxazolo[3,4-a]pyrazine-5,8-dione Chemical class O=C1CNC(=O)C2=COCN12 SPNMSIYOCYTIIH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/02—Preparation
- C07D503/04—Preparation by forming the ring or condensed ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37348310P | 2010-08-13 | 2010-08-13 | |
| PCT/BR2011/000255 WO2012019254A1 (en) | 2010-08-13 | 2011-08-02 | Derivatives of 6, 7-dihydro-3h-oxazolo [3, 4-a] pyrazine-5, 8- dione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1184786A1 true HK1184786A1 (zh) | 2014-01-30 |
Family
ID=45023415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13112233.7A HK1184786A1 (zh) | 2010-08-13 | 2013-10-30 | -二氫- -惡唑並 吡嗪- -二酮的衍生物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8338432B2 (zh) |
| EP (1) | EP2603512B1 (zh) |
| JP (1) | JP5940535B2 (zh) |
| KR (1) | KR101871856B1 (zh) |
| CN (1) | CN103108878B (zh) |
| AR (1) | AR082661A1 (zh) |
| BR (1) | BR112013003225B1 (zh) |
| CA (1) | CA2807872C (zh) |
| CL (1) | CL2013000434A1 (zh) |
| CO (1) | CO6680703A2 (zh) |
| DK (1) | DK2603512T3 (zh) |
| EC (1) | ECSP13012486A (zh) |
| ES (1) | ES2565493T3 (zh) |
| HK (1) | HK1184786A1 (zh) |
| HU (1) | HUE027903T2 (zh) |
| IL (1) | IL224683A (zh) |
| MX (1) | MX347632B (zh) |
| PL (1) | PL2603512T3 (zh) |
| RU (1) | RU2581831C2 (zh) |
| UY (1) | UY33535A (zh) |
| WO (1) | WO2012019254A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY33535A (es) * | 2010-08-13 | 2011-12-01 | Biolab Sanus Farmaceutuca Limitada | Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona |
| AR099523A1 (es) * | 2014-02-24 | 2016-07-27 | Biolab Sanus Farmacêutica Ltda | Compuestos derivados de 6,7-dihidro-3h-oxazolo[3,4-a]pirazina-5,8-diona |
| JP6661606B2 (ja) * | 2014-09-12 | 2020-03-11 | バイオラブ・サヌス・ファーマセウティカ・エルティーディーエー． | 新規ピリドピリミジン誘導体化合物 |
| MX2021015425A (es) | 2019-07-15 | 2022-02-21 | Biolab Sanus Farmaceutica Ltda | Estereoisomeros del compuesto 3-(benzo[d][1,3]dioxol-5-il)-7-(1-hi droxipropano-2-il)-1-(1h-indol-3-il)-6,7-dihidro-3h-oxazol[3,4-a] pirazina-5,8-diona y su uso como antitumoral y inhibidor de la enzima fosfodiesterasa. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698560A (en) | 1995-03-01 | 1997-12-16 | Kyowa Hakko Kogyo Co., Ltd. | Imidazoquinazoline derivatives |
| GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| WO2002098877A1 (en) * | 2001-06-05 | 2002-12-12 | Lilly Icos Llc | Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| US6984641B2 (en) * | 2001-06-21 | 2006-01-10 | Lilly Icos Llc. | Carboline derivatives as PDE5 inhibitors |
| AR045950A1 (es) * | 2003-10-09 | 2005-11-16 | Speedel Experimenta Ag | Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. |
| WO2005097799A1 (en) | 2004-04-07 | 2005-10-20 | Pfizer Limited | Pyrazolo`4,3-d! pyrimidines |
| RU2418590C2 (ru) * | 2006-04-04 | 2011-05-20 | Донг-А Фарматех Ко. Лтд. | Средство для предупреждения и лечения гиперплазии предстательной железы, содержащее производное пиразолопиримидинона |
| BRPI0903803B1 (pt) * | 2009-09-30 | 2019-07-09 | Biolab Sanus Farmacêutica Ltda. | Composto, processo de preparação, composição farmacêutica e uso dos compostos |
| UY33535A (es) * | 2010-08-13 | 2011-12-01 | Biolab Sanus Farmaceutuca Limitada | Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona |
-
2011
- 2011-07-27 UY UY0001033535A patent/UY33535A/es active IP Right Grant
- 2011-08-02 ES ES11815927.6T patent/ES2565493T3/es active Active
- 2011-08-02 CA CA2807872A patent/CA2807872C/en active Active
- 2011-08-02 US US13/196,363 patent/US8338432B2/en active Active
- 2011-08-02 CN CN201180039626.8A patent/CN103108878B/zh active Active
- 2011-08-02 HU HUE11815927A patent/HUE027903T2/hu unknown
- 2011-08-02 BR BR112013003225-1A patent/BR112013003225B1/pt active IP Right Grant
- 2011-08-02 JP JP2013523443A patent/JP5940535B2/ja active Active
- 2011-08-02 WO PCT/BR2011/000255 patent/WO2012019254A1/en active Application Filing
- 2011-08-02 PL PL11815927.6T patent/PL2603512T3/pl unknown
- 2011-08-02 DK DK11815927.6T patent/DK2603512T3/en active
- 2011-08-02 MX MX2013001692A patent/MX347632B/es active IP Right Grant
- 2011-08-02 EP EP11815927.6A patent/EP2603512B1/en active Active
- 2011-08-02 KR KR1020137006343A patent/KR101871856B1/ko active IP Right Grant
- 2011-08-02 RU RU2013110795/04A patent/RU2581831C2/ru active
- 2011-08-09 AR ARP110102892A patent/AR082661A1/es active IP Right Grant
-
2013
- 2013-02-12 CL CL2013000434A patent/CL2013000434A1/es unknown
- 2013-02-12 IL IL224683A patent/IL224683A/en active IP Right Grant
- 2013-03-08 CO CO13046988A patent/CO6680703A2/es active IP Right Grant
- 2013-03-12 EC ECSP13012486 patent/ECSP13012486A/es unknown
- 2013-10-30 HK HK13112233.7A patent/HK1184786A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8338432B2 (en) | 2012-12-25 |
| CO6680703A2 (es) | 2013-05-31 |
| UY33535A (es) | 2011-12-01 |
| RU2581831C2 (ru) | 2016-04-20 |
| AR082661A1 (es) | 2012-12-26 |
| CA2807872A1 (en) | 2012-02-16 |
| EP2603512B1 (en) | 2015-12-30 |
| DK2603512T3 (en) | 2016-04-04 |
| KR20130109110A (ko) | 2013-10-07 |
| EP2603512A4 (en) | 2014-07-16 |
| JP2013533290A (ja) | 2013-08-22 |
| WO2012019254A1 (en) | 2012-02-16 |
| ECSP13012486A (es) | 2013-04-30 |
| MX2013001692A (es) | 2013-03-18 |
| CL2013000434A1 (es) | 2013-06-07 |
| PL2603512T3 (pl) | 2016-09-30 |
| IL224683A (en) | 2016-03-31 |
| EP2603512A1 (en) | 2013-06-19 |
| MX347632B (es) | 2017-05-04 |
| US20120040988A1 (en) | 2012-02-16 |
| BR112013003225B1 (pt) | 2021-03-30 |
| BR112013003225A2 (pt) | 2016-06-07 |
| HUE027903T2 (hu) | 2016-11-28 |
| KR101871856B1 (ko) | 2018-06-28 |
| ES2565493T3 (es) | 2016-04-05 |
| CN103108878B (zh) | 2016-01-27 |
| CA2807872C (en) | 2018-07-24 |
| RU2013110795A (ru) | 2014-09-20 |
| CN103108878A (zh) | 2013-05-15 |
| JP5940535B2 (ja) | 2016-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1179617A1 (zh) | -四氫- 氧氮雜䓬- -基胺或 -四氫- 氧氮雜䓬- -基胺化合物 | |
| HK1187606A1 (zh) | 取代的 -稠合含氮雜環化合物及其用途 | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| IL235819A0 (en) | Preparation of pyrrolo[b–3,2]pyridines | |
| ZA201206440B (en) | [5,6]heterocyclic compound | |
| IL222288A0 (en) | Heterocyclic compounds and their uses | |
| EP2619203A4 (en) | TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | |
| ZA201209297B (en) | 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace) | |
| HK1179608A1 (zh) | 利福昔明的晶型及其用途 | |
| IL221823A (en) | Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors | |
| PT2431442T (pt) | Composição à base de 1,3,3,3-tetrafluoropropeno | |
| IL222900A (en) | Forms of Rifaximin | |
| EP2582664A4 (en) | PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE | |
| ZA201209029B (en) | Novel pyrimidine derivatives | |
| EP2561072A4 (en) | NANOZYMES, PROCESSES FOR PRODUCING NANOZYMES, AND METHODS OF USING NANOZYMES | |
| IL215158A0 (en) | Imidazo [2,1-b] [1,3,4] thiadiazole derivatives | |
| IL223721A0 (en) | Heterocyclic compounds, their preparation and their therapeutic application | |
| EP2640391A4 (en) | PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHOD FOR TREATING COGNITIVE DISORDER | |
| EP2551259A4 (en) | SITAGLIPTIN INTERMEDIATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | |
| EP2558094A4 (en) | PYRIDONE DERIVATIVES | |
| HK1184786A1 (zh) | -二氫- -惡唑並 吡嗪- -二酮的衍生物 | |
| EP2523552A4 (en) | PYRAZOLO- [1,5-A] PYRIMIDINE AS MARK HEMMER | |
| HK1178532A1 (zh) | 用作葡糖激酶激活劑的 -氧代- -二氫- -苯並吡喃並 吡咯類化合物 | |
| EP2593112A4 (en) | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | |
| PT2539328E (pt) | Derivados de furoxano solúveis em água com uma atividade antitumoral |